2004
DOI: 10.1097/01.tp.0000111757.08499.c2
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiologic study on the origin of cancer after kidney transplantation

Abstract: The authors' results suggest that donor transmission of solid cancer is an unlikely event in their population.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0
1

Year Published

2006
2006
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 17 publications
0
12
0
1
Order By: Relevance
“…However, preliminary results from molecular biology studies show that cancer transmission from a clinically healthy donor is very rare (18). Transplants of organs deriving from donors with active cancer or history of neoplasia do not seem to pose a risk of cancer transmission to organ recipients.…”
Section: Discussionmentioning
confidence: 97%
“…However, preliminary results from molecular biology studies show that cancer transmission from a clinically healthy donor is very rare (18). Transplants of organs deriving from donors with active cancer or history of neoplasia do not seem to pose a risk of cancer transmission to organ recipients.…”
Section: Discussionmentioning
confidence: 97%
“…The cancers at highest risk of being transmitted to recipients include central nervous system tumors, choriocarcinoma, breast cancer, renal carcinoma, and lung cancers (94)(95)(96)(97)(98)(99)(100). The overall risk of death from a donor-derived malignancy is well less than 1% (101,102). Organ transplant recipients who are likely to die without their transplants will accept a certain level of risk due to the gravity of their situation.…”
Section: Risk Of Malignancy From Ovarian Cortical Tissue Autotransplamentioning
confidence: 99%
“…The most common type of RCC was clear cell carcinoma (27%, n=9) 7,10,12-14,20,21,31 while the other types were: sarcomatoid (15%, n=5), 2,8 angiosarcoma (6%, n=2), 18 renal papillary tumor (6%, n=2), 28,31 anaplastic (6%, n=2), 25,29 chromophobe (3%, n=1), 16 cystic adenocarcinoma (3%, n=1), 31 anaplastic adenocarcinoma (3%, n=1), 29 giant and spindle cell carcinoma (3%, n=1), 15 and undifferentiated (6%, n=2). 17,22 The type of renal cell carcinoma was not mentioned in the rest (22%, n=7), 2,6,19,31 Other tumors (31%, n=15) comprised 31% of the cases which included: undifferentiated cancer (20%, n=3), 6 invasive urothelial carcinoma (7%, n=1), 24 papillary transitional cell carcinoma of bladder (7%, n=1). 31 Thirty-three percent of the tumors were subsequently found to be benign and the type of cancer was not mentioned in the rest (33%, n=5).…”
Section: Review Of Reported Casesmentioning
confidence: 99%
“…17,22 The type of renal cell carcinoma was not mentioned in the rest (22%, n=7), 2,6,19,31 Other tumors (31%, n=15) comprised 31% of the cases which included: undifferentiated cancer (20%, n=3), 6 invasive urothelial carcinoma (7%, n=1), 24 papillary transitional cell carcinoma of bladder (7%, n=1). 31 Thirty-three percent of the tumors were subsequently found to be benign and the type of cancer was not mentioned in the rest (33%, n=5).…”
Section: Review Of Reported Casesmentioning
confidence: 99%